previou
report
spread
bovin
viru
diarrhoea
viru
bvdv
anim
primarili
infect
agent
contradictori
studi
possibl
transmiss
bvdv
calv
simultan
subject
acut
bvdv
bovin
coronaviru
bcv
infect
investig
ten
calv
inocul
intranas
bvdv
type
calv
randomli
alloc
one
two
group
group
four
addit
calv
result
five
infect
four
suscept
calv
per
group
virul
bcv
activ
introduc
one
group
mean
transmitt
calf
two
calv
suscept
bvdv
bcv
kept
separ
group
control
ten
calv
activ
inocul
bvdv
becam
infect
shown
seroconvers
six
also
shed
viru
nasal
secret
howev
none
eight
calv
two
group
four
seroconvert
agent
contrast
prove
imposs
prevent
spread
bcv
infect
experiment
group
consequ
studi
calv
becam
infect
viru
follow
infect
bcv
detect
nasal
secret
faec
calv
three
week
studi
seroconvert
viru
calv
includ
control
show
least
one
follow
clinic
sign
day
trial
start
fever
c
depress
gener
condit
diarrhoea
cough
studi
show
bvdv
primarili
infect
cattl
even
coinfect
enter
respiratori
pathogen
ineffici
transmitt
bvdv
find
support
principl
scandinavian
bvdv
control
programm
elimin
bvdv
infect
cattl
popul
achiev
identifi
remov
persist
infect
pi
anim
ie
longterm
circul
viru
without
presenc
pi
anim
highli
unlik
bovin
viru
diarrhoea
viru
bvdv
endem
mani
cattl
popul
caus
signific
diseas
problem
econom
loss
control
programm
aim
erad
bvdv
without
use
vaccin
initi
sweden
norway
finland
denmark
husu
kulka
olsson
et
al
bitsch
et
al
waag
et
al
lindberg
aleniu
similar
voluntari
control
programm
also
start
uk
g
gunn
person
commun
scheme
high
prioriti
given
control
measur
direct
toward
livestock
trade
order
control
spread
bvdv
herd
control
measur
focus
exclud
main
transmitt
infect
persist
infect
pi
anim
market
also
prevent
trade
dam
carri
pi
foetus
also
taken
account
risk
introduc
infect
suscept
herd
transmiss
rout
without
initi
presenc
pi
anim
anim
acut
bvdv
infect
transient
period
viral
shed
kirkland
et
al
bolin
ridpath
direct
contact
anim
could
suffici
transmiss
occur
howev
report
abil
acut
infect
anim
serv
vehicl
spread
bvdv
contradictori
attempt
transmit
viru
direct
contact
primarili
infect
suscept
cattl
prove
unsuccess
niskanen
et
al
furthermor
anim
experiment
infect
insemin
parenter
inject
rectal
examin
transmit
infect
suscept
incontact
anim
pritchard
meyl
jensen
langre
et
al
hand
field
studi
larg
herd
shown
differ
result
seroconvers
occur
extend
timeperiod
year
although
presenc
pi
anim
detect
direct
contact
pi
cattl
found
barber
et
al
brownli
et
al
meyl
et
al
moerman
et
al
edward
differ
transmiss
rate
may
explain
part
interact
immunosuppress
factor
relat
viru
strain
environ
manag
procedur
furthermor
primarili
bvdv
infect
anim
could
possibl
play
signific
role
spread
bvdv
infect
presenc
coinfect
exampl
rapid
viru
transmiss
report
aleniu
et
al
may
due
fact
concurr
bovin
coronaviru
bcv
infect
present
coinfect
agent
may
influenc
infect
bvdv
modifi
immunolog
respons
host
increas
amount
viru
excret
aggrav
clinic
sign
cough
nasal
secret
diarrhoea
bovin
coronaviru
common
bovin
pathogen
storz
rott
battaglia
et
al
paton
et
al
tra
et
al
coinfect
viru
bvdv
probabl
occur
frequent
bcv
known
mainli
enter
agent
viru
also
caus
respiratori
tract
infect
calv
mcnulti
et
al
heckert
et
al
storz
et
al
storz
et
al
diseas
highli
contagi
calv
commonli
recov
uncompl
bcv
infect
within
day
tra
experi
describ
paper
allow
us
studi
transmiss
bvdv
calv
simultan
subject
acut
bvdv
bcv
infect
suscept
bcvinfect
calv
twentyon
convent
rear
calv
male
three
femal
obtain
two
differ
close
dairi
herd
herd
certifi
free
bvdv
infect
swedish
control
scheme
bvdv
aleniu
et
al
calv
either
swedish
red
white
breed
sex
friesian
four
male
age
day
arriv
clinic
hous
experiment
unit
one
week
prior
experi
order
avoid
stress
effect
due
transport
chang
environ
calv
shown
free
bvdv
antibodyneg
bvdv
bcv
test
undertaken
herd
origin
day
arriv
cattl
kept
premis
trial
foetal
calf
serum
noncytopathogen
bvdv
type
strain
titr
tcid
per
ml
use
introduc
bvdv
infect
inoculum
given
intranas
ml
spray
nostril
bcv
infect
introduc
experiment
calv
contact
bcvinocul
transmitt
calf
previous
describ
tra
et
al
briefli
bcvcontain
faec
collect
cow
winter
dysenteri
outbreak
store
c
dmso
use
day
ml
faecal
suspens
phosphatebuff
salin
given
stomach
tube
twomonthold
calf
kept
solitari
outdoor
pen
addit
ml
faecal
suspens
instil
nostril
two
day
inocul
transmitt
calf
introduc
experiment
calv
eighteen
calv
match
pair
accord
age
sex
breed
herd
origin
calv
randomli
alloc
one
two
studi
group
b
pair
repres
one
calf
group
two
addit
calv
kept
uninfect
control
group
c
three
group
hous
two
separ
unit
group
b
c
kept
unit
separ
pen
divid
floortoroof
wall
unit
separ
manureshutt
extractor
fan
evacu
stabl
air
fresh
air
enter
unit
via
door
open
unit
close
slide
door
order
reduc
risk
airborn
transmiss
bcv
group
b
c
within
build
day
trial
start
five
calv
group
b
randomli
select
put
isol
pen
day
inocul
intranas
bvdv
staff
perform
clinic
examin
sampl
studi
know
calv
inocul
bvdv
day
calv
return
origin
group
calv
group
infect
bcv
place
contact
bcv
transmit
calf
h
calv
group
nosetonos
contact
bcv
transmitt
twice
contact
period
allow
lie
calv
repeatedli
made
move
around
pen
increas
opportun
transmiss
bcv
transmitt
defaec
h
pen
directli
remov
group
bcv
transmitt
left
experiment
unit
personnel
contact
calv
chang
coat
boot
don
dispos
glove
enter
pen
minim
risk
bcv
transmiss
group
b
c
staff
work
singl
day
either
group
b
group
c
alway
start
group
c
group
alon
serum
sampl
blood
sampl
collect
studi
calv
daili
day
upto
includ
day
day
sampl
drawn
jugular
vein
use
evacu
tube
bectondickinson
centrifug
min
g
sera
transfer
ellerman
tube
store
c
analysi
nasal
swab
faecal
sampl
nasal
swab
virocult
medic
wire
equip
co
bvdv
detect
taken
studi
calv
day
bcv
detect
day
day
bcv
introduc
group
faecal
sampl
bcv
detect
taken
directli
rectal
ampulla
calv
day
day
nasal
swab
faecal
sampl
store
c
analysi
studi
calv
subject
clinic
examin
day
upto
includ
day
examin
follow
paramet
assess
bodi
temperatur
gener
condit
faecal
consist
respiratori
rate
sound
auscult
addit
presenc
cough
conjunctiv
nasal
discharg
record
degre
diarrhoea
cough
respiratori
sound
auscult
nasal
conjunctiv
discharg
convert
numer
valu
valu
rang
correspond
mild
moder
sever
degre
similarli
bodi
temperatur
c
c
b
c
respiratori
rate
b
per
minut
assign
numer
valu
individu
score
gener
condit
bodi
temperatur
diarrhoea
respiratori
tract
involv
calcul
exampl
specif
calf
daili
valu
bodi
temperatur
sum
produc
cumul
bodi
temperatur
score
calf
respiratori
score
includ
score
respiratori
rate
respiratori
sound
auscult
nasal
conjunctiv
discharg
cough
wilcoxon
ranksum
test
appli
stata
softwar
stata
corp
use
test
whether
differ
distribut
clinic
score
signific
bvdvand
bcvinfect
calv
versu
calv
infect
bcv
indirect
enzymelink
immunosorb
assay
elisa
svanova
biotech
use
determin
seroconvers
bvdv
bcv
juntti
et
al
aleniu
et
al
sampl
gener
absorb
valu
regard
posit
bvdv
bcv
antibodi
presenc
bvdv
nasal
swab
detect
immunoperoxidas
test
meyl
bcv
antigen
nasal
swab
faecal
sampl
detect
use
singleco
antigen
elisa
svanova
biotech
sampl
gener
absorb
valu
regard
posit
bcv
wilcoxon
ranksum
test
use
see
whether
signific
differ
number
day
detect
bcv
faecal
shed
dualli
infect
calv
calv
infect
bcv
calv
intranas
inocul
bvdv
becam
infect
viru
seroconvert
bvdv
day
postinfect
pi
howev
seroconvers
detect
eight
calv
group
b
fig
two
control
calv
also
remain
seroneg
bvdv
throughout
observ
period
bvdv
detect
nasal
swab
day
pi
six
calv
intranas
inocul
viru
two
group
four
group
b
two
four
posit
calv
group
b
also
posit
day
pi
one
still
posit
day
eight
nine
pi
tabl
bvdv
isol
nasal
swab
studi
calv
irrespect
trial
group
becam
infect
bcv
mean
absorb
valu
group
day
shown
tabl
ii
three
calv
seroconvert
bcv
day
pi
one
calf
group
b
seroconvert
test
day
remain
calf
group
b
show
seroconvers
day
pi
three
calv
inocul
bvdv
bcv
detect
nasal
swab
andor
faecal
sampl
calv
altogeth
faecal
shed
detect
six
calv
group
three
group
b
calv
group
c
calv
shed
bcv
upto
four
day
faec
tabl
faecal
shed
bcv
occur
two
day
later
group
b
c
group
total
nine
calv
infect
bcv
alon
shed
bcv
faec
three
calv
infect
agent
shed
bcv
faec
detect
level
number
day
faecal
shed
bcv
faec
significantli
lower
p
dualli
infect
calv
calv
infect
bcv
four
calv
group
seven
group
b
shed
bcv
nasal
secret
day
three
andor
day
control
calv
shed
bcv
nasal
secret
day
tabl
calv
includ
control
show
clinic
sign
follow
infect
sign
includ
fever
c
depress
gener
condit
diarrhoea
cough
observ
day
three
median
valu
clinic
score
gener
condit
p
respect
calv
infect
bvdv
bcv
calv
infect
bcv
tabl
iii
correspond
valu
bodi
temperatur
p
total
calv
diarrhoea
eight
dualli
infect
seven
infect
bcv
diarrhoea
last
day
median
clinic
score
p
calv
dual
singl
infect
respect
tabl
iii
respiratori
tract
involv
show
similar
pattern
calv
irrespect
coinfect
statu
day
calv
increas
respiratori
rate
increas
respiratori
sound
auscult
addit
conjuctiv
nasal
discharg
present
calv
cough
median
valu
clinic
score
reflect
respiratori
tract
involv
respect
dualli
infect
calv
calv
infect
bcv
tabl
iii
six
calv
extend
period
fever
day
treat
antibiot
benzylpenicillin
procain
day
day
two
infecti
status
equal
repres
among
calv
four
belong
group
b
tabl
studi
transmiss
bvdv
calv
simultan
subject
acut
bvdv
bcv
infect
wherea
studi
calv
becam
infect
bcv
bvdv
result
agreement
previous
publish
studi
langre
et
al
niskanen
et
al
confirm
experi
ongo
bvdvcontrol
programm
viru
easili
transmit
suscept
cattl
primarili
infect
anim
hand
result
clearli
show
introduct
bcvinfect
anim
result
rapid
spread
bcv
suscept
anim
within
unit
consist
high
morbid
describ
diarrhoea
outbreak
associ
bcv
durham
et
al
saif
aleniu
et
al
calv
inocul
bvdv
becam
infect
shown
seroconvers
six
found
shed
viru
nasal
secret
suscept
incontact
calv
expos
acut
bvdvinfect
calv
excret
hous
togeth
pen
throughout
experi
furthermor
bcv
introduc
theori
facilit
transmiss
bvdv
caus
increas
nasal
secret
cough
diarrhoea
clinic
sign
inde
shown
dualli
infect
calv
addit
coinfect
bcv
trial
may
reduc
nonspecif
resist
consequ
lower
bvdv
dose
requir
infect
bvdvsuscept
incontact
calv
howev
time
coinfect
may
crucial
introduct
bcv
one
day
bvdv
inocul
chosen
ensur
maximum
onset
clinic
sign
bcv
infect
time
bvdv
excret
expect
ie
day
bvdv
inocul
bruschk
also
bcv
introduc
expect
interferon
type
respons
bvdv
infect
day
tra
et
al
order
minim
inhibitori
effect
bcv
replic
inadvert
transmiss
bcv
group
b
also
opportun
studi
effect
bcv
infect
introduc
day
bvdv
infect
suggest
bcv
shed
faec
yet
transmiss
bvdv
occur
either
group
howev
introduct
bcv
bvdv
studi
experi
possibl
suscept
calv
bvdv
challeng
could
increas
preced
bcv
infect
factor
contribut
failur
bvdv
transmiss
may
low
viral
excret
primarili
infect
calv
low
virul
noncytopathogen
bvdv
strain
use
variat
virul
reflect
clinic
sign
bvdv
isol
consider
exampl
anim
infect
certain
bvdv
type
strain
show
seriou
ill
high
viru
titr
serum
prolong
period
time
corapi
et
al
bruschk
carman
et
al
also
possibl
spread
viru
could
demonstr
cytopathogen
biotyp
bvdv
strain
use
experi
furthermor
transmiss
bvdv
might
success
calv
transmitt
suscept
incontact
calv
expos
environment
nutrit
andor
transport
stress
bcv
transmiss
transmitt
calf
calv
group
probabl
occur
contact
nasal
secret
andor
aerosol
sinc
faecal
materi
introduc
pen
group
despit
rigor
measur
taken
prevent
spread
bcv
infect
calv
includ
group
b
c
becam
infect
viru
bcv
infect
highli
contagi
infect
calv
frequent
propag
viru
via
enter
respiratori
tract
simultan
saif
et
al
heckert
et
al
tri
prevent
spread
bcv
via
direct
indirect
rout
group
hous
calv
two
separ
unit
group
one
unit
group
b
c
separ
pen
anoth
unit
unit
locat
approxim
apart
separ
corridor
also
separ
manureshutt
furthermor
personnel
take
care
examin
anim
work
calv
one
unit
one
singl
day
protect
coat
boot
worn
enter
pen
addit
unit
separ
air
duct
extractor
fan
evacu
stabl
air
even
air
may
still
circul
within
build
earli
bcvshed
day
detect
nasal
secret
indic
replic
viru
upper
respiratori
tract
support
hypothesi
rapid
spread
bcv
unit
due
aerosol
transmiss
calv
infect
exclus
bcv
becam
diseas
regard
clinic
sign
alimentari
respiratori
tract
involv
ie
diarrhoea
nasal
conjunctiv
discharg
cough
bcv
found
nasal
secret
faec
calv
infect
confirm
seroconvers
calv
howev
faecal
excret
bcv
significantli
lower
p
dualli
infect
calv
calv
infect
bcv
could
indic
direct
indirect
interfer
bvdv
bcv
replic
possibl
mediat
bvdvinduc
interferon
type
tra
et
al
virul
field
strain
bcv
origin
outbreak
winter
dysenteri
adult
cow
use
introduc
bcv
infect
experiment
calv
clinic
diseas
shown
calv
consist
previous
publish
experiment
studi
demonstr
outcom
bcv
infect
larg
unaffect
origin
viru
cow
calf
isol
rout
inocul
nasal
oral
saif
et
al
elkanawati
et
al
tra
et
al
conclus
studi
calv
becam
infect
bcv
wherea
none
calv
close
contact
primarili
bvdvinfect
calv
conclud
spread
bcv
infect
difficult
prevent
within
cowhous
prevent
spread
bcv
herd
direct
indirect
contact
herd
current
recent
outbreak
diarrhoea
among
cow
andor
calv
avoid
furthermor
suggest
spread
bvdv
infect
like
occur
period
sourc
viru
primarili
infect
anim
consequ
bvdv
seem
contagi
agent
capabl
caus
acut
epizoot
diarrhoea
cattl
herd
provid
pi
anim
introduc
herd
therefor
seem
highli
like
earli
report
bvdv
connect
outbreak
acut
epizoot
diarrhoea
actual
describ
scenario
enter
pathogen
exampl
bcv
coexist
bvdv
escap
detect
due
lack
appropri
viru
diagnost
method
